Increased proliferation activity measured by immunoreactive Ki67 is associated with survival improvement in rectal/recto sigmoid cancer

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 11, Issue 21

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

322

HTML

3008

Figures (1-6)

143

Tables (1-3)

182

Sum=3655

Jun 7, 2005 (publication date) through Aug 27, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Colorectal Cancer

World J Gastroenterol. Jun 7, 2005; 11(21): 3245-3249
Published online Jun 7, 2005. doi: 10.3748/wjg.v11.i21.3245

Full Size Figure Download Figure

Figure 1 Kaplan-Meier survival curve for the whole patient population (n = 146). Five-year median survival 53%, 10-year survival 41%.

Citation: Salminen E, Palmu S, Vahlberg T, Roberts PJ, Söderström KO. Increased proliferation activity measured by immunoreactive Ki67 is associated with survival improvement in rectal/recto sigmoid cancer. World J Gastroenterol 2005; 11(21): 3245-3249
URL: https://www.wjgnet.com/1007-9327/full/v11/i21/3245.htm
DOI: https://dx.doi.org/10.3748/wjg.v11.i21.3245